Agilent is a prominent player in the pharmaceutical industry, specialising as a Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO). The company is renowned for its cutting-edge DNA synthesis platform, which facilitates the provision of fully custom, high-quality oligonucleotide libraries that are suitable for a variety of applications and experimental methodologies. Leveraging advanced chemistries, Agilent enables the creation of highly complex oligo pools and the printing of longer oligonucleotides, thereby serving a diverse range of research and development needs within the sector.

Services include:
- APIs (Active Pharmaceutical Ingredients)
- Regulatory Services
- Containment
- Oligonucleotide Supply
- Custom Synthesis

With a commitment to innovation and quality, Agilent continues to solidify its position as a trusted supplier within the pharmaceutical industry. For further information, please visit agilent.com.